Suppr超能文献

疟原虫蛋白 K13 的 Kelch 突变不会影响青蒿素暴露和山梨醇选择后的休眠。

Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection .

机构信息

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Radcliffe Department of Medicine, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

出版信息

Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02256-17. Print 2018 May.

Abstract

Some Kelch mutations of the K13 protein confer increased survival to dihydroartemisinin (DHA)-treated ring-stage parasites. Here, we asked if K13 mutations affect a dormancy phenotype allowing parasites to survive DHA exposure and then sorbitol selection. Although recrudescence from dormancy differed between two distinct parasite lines, it was similar for isogenic lines carrying single-site substitutions in K13. Therefore, K13 mutations do not alter the DHA-sorbitol combined dormancy phenotype; rather, traits from other loci likely determine this phenotype.

摘要

一些 Kelch 蛋白的突变使疟原虫对二氢青蒿素(DHA)处理的环状期寄生虫的存活能力增加。在这里,我们想知道 K13 突变是否会影响休眠表型,使寄生虫能够在 DHA 暴露后和山梨醇选择中存活。尽管两种不同的寄生虫系之间的复发从休眠中有所不同,但携带 K13 单点突变的同基因系之间的差异相似。因此,K13 突变不会改变 DHA-山梨醇联合休眠表型;相反,其他基因座的特征可能决定了这种表型。

相似文献

1
Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection .
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02256-17. Print 2018 May.
3
K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness .
mBio. 2017 Apr 11;8(2):e00172-17. doi: 10.1128/mBio.00172-17.
4
Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance.
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:49-58. doi: 10.1016/j.ijpddr.2019.10.001. Epub 2019 Oct 4.
8
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.
Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867. Epub 2014 Dec 11.
10
In vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations.
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:20-27. doi: 10.1016/j.ijpddr.2019.04.002. Epub 2019 Apr 10.

引用本文的文献

1
Epigenetically conferred ring-stage survival in Plasmodium falciparum against artemisinin treatment.
Nat Commun. 2025 Aug 28;16(1):8037. doi: 10.1038/s41467-025-62479-2.
2
Isolation and characterization of blood-stage persisters by improved selection protocols using dihydroartemisinin alone.
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0005324. doi: 10.1128/aac.00053-24. Epub 2025 Feb 10.
3
Artemisinin-resistant malaria.
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15.
4
Progressive heterogeneity of enlarged and irregularly shaped apicoplasts in persister blood stages after drug treatment.
PNAS Nexus. 2024 Sep 24;3(10):pgae424. doi: 10.1093/pnasnexus/pgae424. eCollection 2024 Oct.
9
Nutrient Limitation Mimics Artemisinin Tolerance in Malaria.
mBio. 2023 Jun 27;14(3):e0070523. doi: 10.1128/mbio.00705-23. Epub 2023 Apr 25.

本文引用的文献

1
Mitochondrial Membrane Potential in a Small Subset of Artemisinin-Induced Dormant Plasmodium falciparum Parasites In Vitro.
J Infect Dis. 2015 Aug 1;212(3):426-34. doi: 10.1093/infdis/jiv048. Epub 2015 Jan 29.
2
Genetic architecture of artemisinin-resistant Plasmodium falciparum.
Nat Genet. 2015 Mar;47(3):226-34. doi: 10.1038/ng.3189. Epub 2015 Jan 19.
3
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.
Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867. Epub 2014 Dec 11.
4
Dihydroartemisinin-piperaquine failure in Cambodia.
N Engl J Med. 2014 Jul 31;371(5):484-5. doi: 10.1056/NEJMc1403007.
5
Spread of artemisinin resistance in Plasmodium falciparum malaria.
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
6
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system.
Nat Biotechnol. 2014 Aug;32(8):819-21. doi: 10.1038/nbt.2925. Epub 2014 Jun 1.
7
Flow cytometry-based analysis of artemisinin-resistant Plasmodium falciparum in the ring-stage survival assay.
Antimicrob Agents Chemother. 2014 Aug;58(8):4938-40. doi: 10.1128/AAC.02902-14. Epub 2014 May 27.
8
Malaria biology and disease pathogenesis: insights for new treatments.
Nat Med. 2013 Feb;19(2):156-67. doi: 10.1038/nm.3073. Epub 2013 Feb 6.
9
Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.
Antimicrob Agents Chemother. 2013 Feb;57(2):914-23. doi: 10.1128/AAC.01868-12. Epub 2012 Dec 3.
10
Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.
Antimicrob Agents Chemother. 2012 Jan;56(1):302-14. doi: 10.1128/AAC.05540-11. Epub 2011 Nov 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验